The MEDIGENE IMMUNOTHERAPIES brand, founded in 2015 (Germany), from 14 sister brands and 2214 competing brands. MEDIGENE IMMUNOTHERAPIES is a brand of Medigene, listed on the stock exchange of Francfort. The International Securities Identification Number (ISIN) of Medigene is DE000A1X3W00. The sector of MEDIGENE IMMUNOTHERAPIES is Biotechnology.

MEDIGENE IMMUNOTHERAPIES is a brand of Medigene (MDG1) Share price

International deposit : 2015 Business sector Biotechnology

Share price and profitability of the share Medigene (MEDIGENE IMMUNOTHERAPIES)

Buy Medigene share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 1.50

Portfolio valuation
Medigene (MEDIGENE IMMUNOTHERAPIES) over 5 years* EUR 0.27

Stock market history Medigene (MEDIGENE IMMUNOTHERAPIES)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Medigene

See more brands of Medigene

Rival brands
MEDIGENE IMMUNOTHERAPIES

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS